Duopharma Biotech Berhad

RM 1.11As of Sun 8 Nov 2026, 12:00 UTC
KLSE:DPHARMAHealthcare
Country Malaysia
PE (Fwd) •••
TSR 10Y CAGR 7.56%
Div yield 4.10%
ROE 13.43%
Pharmaceutical Preparations
Beta (5Y) 0.38
PE TTM 10.45
TSR TTM (8.24%)
Mkt cap RM 1.068B
ROIC 11.71%
SE Grade™
Value
Quality
Moat
Consensus
Reference
RM 1.08
(2.91%)
(84.93%)
Hold 11|0|9|12|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareRM
0.01
0.01
0.01
0.01
7.91%
12.78%
10.25%
17.14%
RevenueRM M
80.52
81.59
82.93
84.43
(1.58%)
0.79%
(0.50%)
2.83%
Peers (US$263.2M)
Cap (US$)
PE
561.7M
8.333x
Capital
TTM
5Y
10Y
Leveragex
0.449
0.201
0.201
EBIT/Intx
1.075
0.221
0.229
Own earn%
13.11
13.56
13.26
Sh yield%
33.42
62.06
61.00
Owners
Insiders/Inst%
14.03
83.42
Short interest%
1.90
SBC / revenue%
3.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
6–11
$1 testx
—
Incr. ROIC%
5